Parse Biosciences, also known as Split Biosciences, is a biotechnology company headquartered in Seattle, Washington. It was founded in 2018 and specializes in developing single-cell sequencing platforms for research purposes. Its flagship product is the Whole Transcriptome Kit, a solution for single-cell RNA sequencing. This platform allows researchers to analyze the gene expression of individual cells efficiently and with scalability​

The company has secured $8.5 million in funding and serves approximately 150 enterprise customers. Its innovative technology supports various life sciences applications, including healthcare, genetics, and biotech research. Parse Biosciences aims to make single-cell sequencing accessible and widely applicable in scientific and medical fields